Lupin CEO Highlights Structural Support For Generics Pricing, Sees gMyrbetriq Relaunch

Liraglutide, Pegfilgrastim Launches In FY26

Revenues
Lupin Expects Increased Revenues From Higher Structural Support, New Launches • Source: Shutterstock

More from Business

More from Scrip